Back to search

Article

Investigating the impact of OCT transporter genotype on metformin-induced vitamin B12 deficiency

2016-01-01

Abstract excerpt

Metformin is the first-line therapy for the treatment of Type 2 Diabetes Mellitus (T2DM) and is the most widely prescribed anti-diabetic drug in the world. A common and potentially hazardous side-effect of metformin treatment is vitamin B12 deficiency. OCT1 (SLC22A1) and OCT2 (SLC22A2) are highly polymorphic drug transporters responsible for the hepatic and renal uptake of metformin, respectively. Studies have doc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e7e63d26-aa10-5dd5-9379-141ed95a325b
DOI
10.17638/03001170
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Investigating the impact of OCT transporter genotype on metformin-induced vitamin B12 deficiencyDOI 10.17638/03001170
Select a neighboring publication to make it the new centre.